🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our new paper on immune set points and ZIKV responses, and congrats to 1st author Elizabeth McCarthy and team! A terrific collaboration with Rachel Rutishauser (moving to bsky: rrutishauser)!

Excited to share our new paper discerning an immune trajectory of recovery in hospitalized COVID-19 patients. Congrats to Casey Burnett Trine Line Hauge Okholm Iliana Tenvooren & team! And a big thank you to Kavitha Scranton Immunity! cell.com/immunity/fullt…

We are recruiting postdocs passionate about understanding immune response dynamics to develop new cancer immunotherapies. Wonderful collaborative community at UC San Francisco UCSF Bakar ImmunoX Initiative Gladstone Institutes Parker Institute for Cancer Immunotherapy! Please get in touch if interested (and please RT)!

We are hiring a lab manager! Come join our collaborative and dynamic team and lead an exciting project in cancer immunotherapy! Here's the link: aprecruit.ucsf.edu/JPF03276 and please RT

Incredibly excited and honored to have been selected for the HHMI #GilliamFellows award! A huge shoutout to my incredibly supportive PI Matt Spitzer, the SpitzerLab, Justin Eyquem , Priscila Muñoz Sandoval , ImmunoDiverse, Tammy Chang and the entire UC San Francisco community! 🎉

Thank you so much to HHMI #GilliamFellows for supporting the amazing Maya as a new Fellow! It is an honor to support her scientific journey as her adviser! hhmi.org/news/hhmi-awar…

In the latest issue! Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes dlvr.it/Sl6Vzv

SPOTLIGHT: UC San Francisco Maha Rahim SpitzerLab demonstrated the differential role of uninvolved (uiLNs) and metastatic (met-LNs) lymph nodes in orchestrating antitumor responses in human HNSCC bit.ly/3JyLQ4N #ClinicalTrial #DCs

Excited to share that our work on regional T cell clonal responses to immune checkpoint blockade is out now! Very grateful to Andrew Chow, Matthew Hellmann, Ansu Satpathy, and all other co-authors for this wonderful collaboration. Check it out here! authors.elsevier.com/c/1gqic_Ywcvmm…

Please join us in congratulating the newly minted Dr. Rachel DeBarge! @racheldebarge has not only immensely contributed to the research conducted in the lab but also acted as a trusted mentor to many students/trainees. We will miss them but can't wait to see what they do next! 🎉

More celebration is in order: Dr. Casey Burnett delivered a fantastic exit talk today! Casey Burnett has been an invaluable and impactful member of our and the Roybal Lab, and we look forward to seeing her succeed in her next steps! Congratulations! 🎉🎉

We're so lucky to have Kathy as a colleague! Excited for more great science from her! 👏

14/16 #Pezcoller24 Symposium Speaker Immune Checkpoint Blockade has shown remarkable efficacy in a subset of patients but many cancers remain durably resistant to ICB Looking forward to learning about Sophia Guldberg’s results -SpitzerLab UC San Francisco 10days to go! pezcoller.it/en/events/symp…

🚀 Attention aspiring postdocs! We're hunting for passionate candidates in immunology & cell engineering for cutting-edge immunotherapy research. If you’re ready to do cool science with an awesome team in an amazing place, apply! #Postdoc #Immunotherapy opportunities.ucsf.edu/content/postdo…

Congratulations to our 4 PhD candidates who recently passed their qualifying exams (left to right): Minna Apostolova, McKenzie Daanen, Zach, and Jing-Yi Chung! We're so excited to see some great science from them in the next few years! 🎉🥳